Based on the type of mutation and degree of arylsulfatase A enzyme (ARSA) deficiency, MLD can show a wide spectrum of clinical manifestations that range from cognitive impairment to progressive abnormalities of motor and language function and early death [1,2]. This evidence concerns the gene ARSA and hyperinsulinemic hypoglycemia, familial, 4.